title: Evaluation of the efficiency of cefoxitin/cefepime combination against Enterobacteriaceae resistant to expanded-spectrum cephalosporins.
authors.affiliation: Laboratoire de Bactériologie, Centre Hospitalo-Universitaire Clermont-Ferrand, Clermont-Ferrand, France.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Serres
authors.affiliation: Laboratoire de Bactériologie, Centre Hospitalo-Universitaire Clermont-Ferrand, Clermont-Ferrand, France; Microbes, Intestins, Inflammation et Susceptibilité de l'Hôte, INSERM U1071, INRA USC2018, Université d'Auvergne, Clermont-Ferrand, France.
authors.forename: Lucie
authors.initials: L
authors.lastname: Gibold
authors.affiliation: Microbes, Intestins, Inflammation et Susceptibilité de l'Hôte, INSERM U1071, INRA USC2018, Université d'Auvergne, Clermont-Ferrand, France.
authors.forename: Guillaume
authors.initials: G
authors.lastname: Dalmasso
authors.affiliation: Laboratoire de Bactériologie, Centre Hospitalo-Universitaire Clermont-Ferrand, Clermont-Ferrand, France; Microbes, Intestins, Inflammation et Susceptibilité de l'Hôte, INSERM U1071, INRA USC2018, Université d'Auvergne, Clermont-Ferrand, France.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Robin
authors.affiliation: Laboratoire de Bactériologie, Centre Hospitalo-Universitaire Clermont-Ferrand, Clermont-Ferrand, France; Microbes, Intestins, Inflammation et Susceptibilité de l'Hôte, INSERM U1071, INRA USC2018, Université d'Auvergne, Clermont-Ferrand, France.
authors.forename: Richard
authors.initials: R
authors.lastname: Bonnet
authors.affiliation: Laboratoire de Bactériologie, Centre Hospitalo-Universitaire Clermont-Ferrand, Clermont-Ferrand, France; Microbes, Intestins, Inflammation et Susceptibilité de l'Hôte, INSERM U1071, INRA USC2018, Université d'Auvergne, Clermont-Ferrand, France. Electronic address: jdelmas@chu-clermontferrand.fr.
authors.forename: Julien
authors.initials: J
authors.lastname: Delmas
mesh_terms: D000825:Animal Structures / Q000382:microbiology; D000818:Animals; D058491:Bacterial Load; D000077723:Cefepime; D002440:Cefoxitin / Q000494:pharmacology / Q000627:therapeutic use*; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D004755:Enterobacteriaceae / Q000187:drug effects* / Q000201:enzymology / Q000302:isolation & purification; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000382:microbiology / Q000473:pathology; D006801:Humans; D051379:Mice; D008826:Microbial Sensitivity Tests; D016019:Survival Analysis; D016896:Treatment Outcome; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000378:metabolism
chemical_list: D002511:Cephalosporins; D002440:Cefoxitin; D000077723:Cefepime; D001618:beta-Lactamases
keywords: AmpC β-lactamase; Antibiotic resistance; Cefepime; Cefoxitin; ESBL; Gram-negative